{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:16:02Z","timestamp":1792541762135,"version":"4.5.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.juro.2014.10.121","type":"journal-article","created":{"date-parts":[[2014,11,17]],"date-time":"2014-11-17T13:18:30Z","timestamp":1416230310000},"page":"1163-1169","source":"Crossref","is-referenced-by-count":255,"title":["The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer"],"prefix":"10.1097","volume":"193","author":[{"given":"Stacy","family":"Loeb","sequence":"first","affiliation":[{"name":"Department of Urology and Population Health, New York University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin G.","family":"Sanda","sequence":"additional","affiliation":[{"name":"Department of Urology, Emory University and Emory Healthcare, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis L.","family":"Broyles","sequence":"additional","affiliation":[{"name":"Beckman Coulter Incorporated, Carlsbad, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghyuk S.","family":"Shin","sequence":"additional","affiliation":[{"name":"Beckman Coulter Incorporated, Carlsbad, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris H.","family":"Bangma","sequence":"additional","affiliation":[{"name":"Department of Urology, Erasmus University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Michigan School of Medicine, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan W.","family":"Partin","sequence":"additional","affiliation":[{"name":"Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George G.","family":"Klee","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Slawin","sequence":"additional","affiliation":[{"name":"Vanguard Urologic Institute and Texas Prostate Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard S.","family":"Marks","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California Los Angeles, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron H.N.","family":"van Schaik","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W.","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori J.","family":"Sokoll","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amabelle B.","family":"Cruz","sequence":"additional","affiliation":[{"name":"Beckman Coulter Incorporated, Carlsbad, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac A.","family":"Mizrahi","sequence":"additional","affiliation":[{"name":"Beckman Coulter Incorporated, Carlsbad, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Catalona","sequence":"additional","affiliation":[{"name":"Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2014.10.121_bib1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","article-title":"Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement","volume":"157","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.juro.2014.10.121_bib2","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/S0140-6736(14)60525-0","article-title":"Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up","volume":"384","author":"Schroder","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.juro.2014.10.121_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/jnci\/djr500","article-title":"Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up","volume":"104","author":"Andriole","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2014.10.121_bib4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0022-5347(17)35408-3","article-title":"Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer","volume":"150","author":"Christensson","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2014.10.121_bib5","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.eururo.2013.01.011","article-title":"Serum\u00a0isoform [-2]proPSA derivatives significantly improve prediction of prostate cancer at\u00a0initial biopsy in a total PSA range of 2-10\u00a0ng\/ml: a multicentric European study","volume":"63","author":"Lazzeri","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2014.10.121_bib6","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/01.ju.0000086940.10392.93","article-title":"Evaluation of proprostate specific antigen for early detection of prostate cancer in men with a total prostate specific antigen range of 4.0 to 10.0 ng\/ml","volume":"170","author":"Khan","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2014.10.121_bib7","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.juro.2010.12.032","article-title":"A\u00a0multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng\/ml prostate specific antigen range","volume":"185","author":"Catalona","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2014.10.121_bib8","doi-asserted-by":"crossref","first-page":"763.e1","DOI":"10.1016\/j.urology.2010.07.526","article-title":"ProPSA and diagnostic biopsy tissue DNA content combination improves accuracy to predict need for prostate cancer treatment among men enrolled in an active surveillance program","volume":"77","author":"Isharwal","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.juro.2014.10.121_bib9","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.juro.2012.06.009","article-title":"Association of [-2]proPSA with biopsy reclassification during active surveillance for prostate cancer","volume":"188","author":"Tosoian","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2014.10.121_bib10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00432-013-1566-2","article-title":"The impact of baseline [-2]proPSA-related indices on the prediction of pathological reclassification at 1 year during active surveillance for low-risk prostate cancer: the Japanese multicenter study cohort","volume":"140","author":"Hirama","year":"2014","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.juro.2014.10.121_bib11","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.eururo.2010.02.003","article-title":"Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection","volume":"50","author":"Jansen","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2014.10.121_bib12","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/j.juro.2007.08.039","article-title":"Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience","volume":"178","author":"Carter","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2014.10.121_bib13","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1002\/sim.2459","article-title":"New confidence intervals for the difference between two sensitivities at a fixed level of specificity","volume":"25","author":"Qin","year":"2006","journal-title":"Stat Med"},{"key":"10.1016\/j.juro.2014.10.121_bib14","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a\u00a0nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.juro.2014.10.121_bib15","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s11255-013-0582-0","article-title":"The Prostate Health Index in predicting initial prostate biopsy outcomes in Asian men with prostate-specific antigen levels of 4-10 ng\/mL","volume":"46","author":"Ng","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.juro.2014.10.121_bib16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00345-012-0927-9","article-title":"Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng\/mL range","volume":"31","author":"Ito","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.juro.2014.10.121_bib17","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1373\/clinchem.2012.195784","article-title":"Multicenter evaluation of [-2]proprostate-specific antigen and the Prostate Health Index for detecting prostate cancer","volume":"59","author":"Stephan","year":"2013","journal-title":"Clin Chem"},{"key":"10.1016\/j.juro.2014.10.121_bib18","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1515\/cclm-2012-0410","article-title":"Evaluation of [-2] proPSA and Prostate Health Index (phi) for the detection of prostate cancer: a systematic review and meta-analysis","volume":"51","author":"Filella","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.juro.2014.10.121_bib19","unstructured":"National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Prostate Cancer Early Detection Version 2014. Available at http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate_detection.pdf. Accessed May 26, 2014."},{"issue":"suppl.","key":"10.1016\/j.juro.2014.10.121_bib20","doi-asserted-by":"crossref","first-page":"e843","DOI":"10.1016\/j.juro.2013.02.2473","article-title":"Reducing unnecessary biopsies for suspicion of prostate cancer: extension and validation of an ERSPC based risk calculator with phi and comparison with the PCPT risk calculator including %free and -2proPSA","volume":"189","author":"Roobol","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2014.10.121_bib21","doi-asserted-by":"crossref","unstructured":"Roobol M, Salman J and Azevedo N: The Rotterdam prostate cancer risk calculator: improved prediction with more relevant pre-biopsy information, now in the palm of your hand. Presented at EAU Stockholm, April 11-15, 2014, abstract 857.","DOI":"10.1016\/j.juro.2014.02.1522"},{"key":"10.1016\/j.juro.2014.10.121_bib22","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.juro.2009.10.003","article-title":"Accuracy of PCA3 measurement in predicting short-term biopsy progression in an active surveillance program","volume":"183","author":"Tosoian","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2014.10.121_bib23","doi-asserted-by":"crossref","first-page":"e67687","DOI":"10.1371\/journal.pone.0067687","article-title":"Prostate\u00a0Health Index (Phi) and prostate cancer antigen 3 (PCA3) significantly improve prostate\u00a0cancer detection at initial biopsy in a total\u00a0PSA\u00a0range of 2-10 ng\/ml","volume":"8","author":"Ferro","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.juro.2014.10.121_bib24","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.eururo.2013.12.062","article-title":"Overdiagnosis and overtreatment of prostate cancer","volume":"65","author":"Loeb","year":"2014","journal-title":"Eur Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534714049003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534714049003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2014.10.121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T03:57:21Z","timestamp":1651204641000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2014.10.121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["10.1016\/j.juro.2014.10.121"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2014.10.121","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}